Hepatic Stenosis: Diagnostic Work-Up and Management
Initial Diagnostic Approach
For any suspected hepatic stenosis involving the hepatic artery, portal vein, hepatic vein, or biliary tree, begin with Doppler ultrasound as the first-line imaging modality, followed by multiphasic contrast-enhanced CT or MRI to characterize the stenosis and assess for complications. 1
Vascular Stenosis Evaluation
Hepatic Artery Stenosis:
- Doppler ultrasound should assess peak flow velocity (>80 cm/sec suggests stenosis), resistivity index (<0.55 abnormal), and hepatic artery diameter (>6 mm extrahepatic dilatation indicates stenosis) 1
- Multiphasic CT angiography with late arterial, portal venous, and delayed phases provides 84% sensitivity and 95% specificity for hepatic artery involvement 1
- CT findings of stenosis or occlusion are highly suggestive for arterial involvement, while absence of tumor-vessel contact has very high negative predictive value 1
- In post-transplant patients, hepatic artery stenosis occurs in 3-5% of cases, with median diagnosis at 100 days post-transplant 2, 3
Portal Vein Stenosis:
- Doppler ultrasound should measure flow velocity within the portal vein trunk and assess for flow direction abnormalities 1
- CT angiography demonstrates 89% sensitivity and 92% specificity for portal vein involvement 1
- Look for circumferential contact >180°, encasement, occlusion, stenosis, or contour deformity 1
Hepatic Vein Stenosis:
- Doppler ultrasound should assess hepatic vein flow patterns and detect flow abnormalities 1
- Hepatic vein stenosis occurs in 1-6% of post-transplant patients and can cause portal hypertension, renal dysfunction, or lower-extremity edema 2
- MRI with contrast can provide additional anatomical detail when ultrasound findings are equivocal 1
Biliary Stenosis Evaluation
Intrahepatic Biliary Tree Stenosis:
- MRCP with long T2 single-shot sequences provides superior visualization of biliary anatomy and extent of stenosis compared to CT 1
- Assess for upstream and downstream extension of obstruction, variant ductal anatomy, and associated complications 1
- In post-transplant patients, biliary strictures occur in 33% of those with hepatic artery stenosis versus 7.1% without vascular compromise 4
Management Algorithm
For Hepatic Artery Stenosis
Post-Transplant Setting:
- Immediate surgical revision is indicated when stenosis causes liver dysfunction or threatens graft survival 3
- Revision options include: resection with primary reanastomosis (preferred for focal stenosis), aortohepatic iliac artery graft, interposition vein graft, or vein patch angioplasty 3
- Percutaneous transluminal balloon angioplasty can be attempted for focal, non-calcified stenoses, though long-term patency is lower than surgical revision 3
- Post-revision hepatic artery patency is achieved in 78% of cases, with 4-year patient survival of 65% 3
Non-Transplant Setting:
- Evaluate for underlying malignancy (cholangiocarcinoma) as stenosis may represent tumor encasement 1
- If malignant, assess resectability based on extent of vascular involvement and presence of metastases 1
For Portal Vein Stenosis
Budd-Chiari Syndrome or Hepatic Vein Stenosis:
- Immediate anticoagulation with low molecular weight heparin for 5-7 days, transitioning to vitamin K antagonist targeting INR 2-3 1
- Angioplasty with stenting for partial or segmental stenoses (present in 60% of IVC obstruction, 25-30% of hepatic vein obstruction) 1
- TIPS placement for patients non-responsive to medical treatment or not candidates for angioplasty/stenting 1
- Monitor with Doppler ultrasound every 6 months to assess TIPS patency and flow velocities 1
Portal Vein Thrombosis with Stenosis:
- Beta-adrenergic blockade decreases bleeding risk in patients with large varices and improves survival 1
- Endoscopic variceal band ligation for primary or secondary prophylaxis of variceal bleeding 1
- Consider surgical portosystemic shunting using superior mesenteric or splenic veins in selected patients 1
For Biliary Stenosis
Post-Transplant Ischemic Biliary Strictures:
- Biliary strictures develop in 40% of patients with early hepatic artery stenosis (≤90 days) and 26% with late stenosis (>90 days) 4
- ERCP with repeated stenting for symptomatic strictures causing jaundice or cholangitis 1
- Risk of hemobilia from intrabiliary varices during endobiliary procedures—proceed with caution 1
- Liver function test elevation ≥3× upper limit of normal at diagnosis indicates higher likelihood of requiring biliary intervention 4
Malignant Biliary Stenosis:
- Tissue diagnosis via ERCP with brush cytology (40-70% sensitivity) or direct bile aspirate for methylation markers (100% sensitivity, 90% specificity in PSC-related cholangiocarcinoma) 1
- Avoid percutaneous biopsy due to risk of tumor spillage 5
Critical Monitoring and Follow-Up
Post-Intervention Surveillance:
- Doppler ultrasound at 4-6 weeks post-intervention, then every 6 months to assess patency 1
- Measure maximum flow velocity in portal vein and stent, assess flow direction in intrahepatic portal vein branches 1
- Invasive portography with pressure measurement only when ultrasound suggests dysfunction or clinical failure occurs 1
Complications to Monitor:
- Hepatic encephalopathy develops in 15-67% over 2 years after TIPS, with 8% persistent overt encephalopathy 1
- Biliary complications requiring intervention are more likely when liver enzymes are significantly elevated at stenosis diagnosis 4
- Retransplantation may be necessary if graft function deteriorates despite vascular revision 3
Common Pitfalls
- Do not delay anticoagulation in hepatic vein stenosis/Budd-Chiari syndrome—bleeding risk is manageable with proper portal hypertension prophylaxis 1
- Do not perform routine invasive portography for TIPS surveillance—reserve for clinical or ultrasound suspicion of dysfunction 1
- Do not assume biliary strictures are benign in the setting of vascular stenosis—ischemic injury is common and progressive 4
- Do not overlook hepatic artery stenosis as a cause of biliary complications in transplant patients—33% will develop strictures 4